This newsletter presents you the following key sessions:
1. Podcast with Dr. Zev Wainberg: Updated results of the NAPOLI 3 trial comparing NALIRIFOX versus nab-
paclitaxel plus gemcitabine in metastatic pancreatic ductal adenocarcinoma
2. Podcast with Dr. Ronan Kelly: First report of comprehensive biomarker analyses from CheckMate 577
evaluating adjuvant nivolumab vs. placebo in resected oesophageal or gastroesophageal junction cancer
3. Podcast with Dr. Akihito Kawazoe: Results of the LEAP-017 trial comparing lenvatinib plus pembrolizumab
vs. placebo in patients with previously treated metastatic colorectal cancer
4. Podcast with Dr. Sakti Chakrabarti: Anti-HER2 therapy following ctDNA-identified ERBB2 amplification for
patients with advanced gastric cancer